CHRISTIAN BOUDREAUX: Open Payments
NPI 1922637586 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,650 in 102 payments from 18 companies in 2025. Trend: 2023 $280 · 2024 $1,356 · 2025 $2,650
Food & beverage: $2,411Education: $239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $469 |
| Janssen Biotech, Inc. | 12 | $431 |
| Galderma Laboratories, L.P. | 18 | $365 |
| GENZYME CORPORATION | 4 | $296 |
| UCB, Inc. | 5 | $180 |
| PFIZER INC. | 5 | $152 |
| Lilly USA, LLC | 6 | $121 |
| Incyte Corporation | 5 | $107 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $81 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, Bimzelx, CIBINQO, BOTOX, TALTZ.
Industry payments across TX — which companies pay providers there.
